Howard Lee has led the SōRSE team since
2016, which to date has tripled in size. He has
brought SōRSE to the international marketplace
through licensing agreements with The Valens
Company and FCM Global and into the medical
space through a cancer research partnership
with Pascal Biosciences.

Howard brings over 20 years of leadership
experience in the tech industry and enterprise
world, having served as CEO and founder of
multiple start-ups where he was responsible
for raising seed funding; Series A, B, C funding;
and growth equity rounds.